Stephanie L. Lee MD, PhD

Professor, Endocrinology, Diabetes, Nutrition & Weight Management

720 Harrison Ave | (617) 638-8530
sltal@bu.edu
stephanie.lee@bmc.org

Sections

Endocrinology, Diabetes, Nutrition & Weight Management

Centers

BU-BMC Cancer Center

Evans Center for Interdisciplinary Biomedical Research

Biography

Stephanie L. Lee, Ph.D., M.D., F.A.C.E., E.C.N.U graduated from UC San Diego with a MD and PhD in Physiology and Pharmacology and completed a molecular and clinical fellowship in Endocrinology. Her research interests are to improve the methods to diagnosis and manage thyroid cancer.

Websites

BU Profile

Boston Medical Center Provider Profile

BU Nanotechnology Innovation Center (BUnano)

World Congress on Thyroid Cancer Profile

ResearchGate

Education

MD, University of California, San Diego

PhD, University of California, San Diego

BA, University of California, Santa Barbara

Publications

Published on 2/2/2024

Goundan PN, Lye T, Markel A, Mamou J, Lee SL. Improved cancer risk stratification of isoechoic thyroid nodules to reduce unnecessary biopsies using quantitative ultrasound. Front Endocrinol (Lausanne). 2024; 15:1326188. PMID: 38370358.

PubMed

Published on 9/27/2023

Kang H, Drake FT, McAneny D, Lee SL. False-positive Imaging for Papillary Thyroid Cancer Caused by Intraosseous Hemangiomas. JCEM Case Rep. 2023 Sep; 1(5):luad102. PMID: 37908210.

PubMed

Published on 8/1/2023

Sipos JA, Aloi J, Gianoukakis A, Lee SL, Klopper JP, Kung JT, Lupo MA, Morgenstern D, Prat-Knoll C, Schuetzenmeister A, Goldner WS. Thyroglobulin Cutoff Values for Detecting Excellent Response to Therapy in Patients With Differentiated Thyroid Cancer. J Endocr Soc. 2023 Aug 01; 7(9):bvad102. PMID: 37564885.

PubMed

Published on 10/31/2022

Sarkar R, Lee SL, Kumar V, Thakur S. Editorial: Thyroid cancer: New perspectives in diagnosis and therapy. Front Pharmacol. 2022; 13:1057731. PMID: 36386151.

PubMed

Published on 2/14/2022

Pence A, McGrath M, Lee SL, Raines DE. Pharmacological management of severe Cushing's syndrome: the role of etomidate. Ther Adv Endocrinol Metab. 2022; 13:20420188211058583. PMID: 35186251.

PubMed

Published on 5/19/2021

Goundan PN, Mamou J, Rohrbach D, Smith J, Patel H, Wallace KD, Feleppa EJ, Lee SL. A Preliminary Study of Quantitative Ultrasound for Cancer-Risk Assessment of Thyroid Nodules. Front Endocrinol (Lausanne). 2021; 12:627698. PMID: 34093429.

PubMed

Published on 12/15/2020

Haddady S, Pinjic E, Lee SL. Prognostic Value of Serum Thyroglobulin Measured at 48 Hours Versus 72 Hours after Second Dose of Recombinant Human Thyrotropin in Surveillance of Well-Differentiated Thyroid Cancer. Endocr Pract. 2021 Mar; 27(3):216-222. PMID: 33779554.

PubMed

Published on 12/3/2020

Vodopivec DM, Thomas DD, Palermo NE, Steenkamp DW, Lee SL. Looking for the Outsider. N Engl J Med. 2020 12 03; 383(23):2275-2281. PMID: 33264549.

PubMed

Published on 11/1/2020

Guan H, Toraldo G, Godley FA, Rao SR, Cerda S, McAneny D, Doherty G, Lee SL. The real-world performance of ThyroSeqV.2 to diagnose thyroid "neoplasm requiring surgery". Am J Cancer Res. 2020; 10(11):3838-3851. PMID: 33294271.

PubMed

Published on 10/1/2020

Goundan PN, Lee SL. Thyroid effects of amiodarone: clinical update. Curr Opin Endocrinol Diabetes Obes. 2020 10; 27(5):329-334. PMID: 32773570.

PubMed

View full list of 75 publications.